Alternative medicine and doping in sports by Benjamin Koh et al.
 Australasian Medical Journal [AMJ 2012, 5, 1, 18-25] 
 
 
18 
             
Alternative medicine and doping in sports 
Benjamin Koh,1 Lynne Freeman,2 Christopher Zaslawski3  
1. Independent Medical Practitioner and Researcher, Management Discipline Group, University of 
Technology (UTS) 
2. Lecturer in Qualitative Research, Marketing Discipline Group, UTS  
3. Director, College of Traditional Chinese Medicine, Faculty of Science, UTS 
 
                                   REVIEW 
  
Please cite this paper as:  Koh B, Freeman L, Zaslawski C. 
Alternative medicine and doping in sports. AMJ 2012, 5, 1, 
18-25. http//dx.doi.org/10.4066/AMJ.2012.1079 
 
 
 
 
  
 
 
 
Abstract 
 
Athletes  are  high  achievers  who  may  seek  creative  or 
unconventional  methods  to  improve  performance.  The 
literature  indicates  that  athletes  are  among  the  heaviest 
users  of  complementary  and  alternative  medicine  (CAM) 
and thus may pioneer population trends in CAM use. Unlike 
non-athletes, athletes may use CAM not just for prevention, 
treatment or rehabilitation from illness or injuries, but also 
for  performance  enhancement.  Assuming  that  athletes’ 
creative  use  of  anything  unconventional  is  aimed  at 
“legally”  improving  performance,  CAM  may  be  used 
because it is perceived as more “natural” and erroneously 
assumed as not potentially doping. This failure to recognise 
CAMs  as  pharmacological  agents  puts  athletes  at  risk  of 
inadvertent doping. 
 
The  general  position  of  the  World  Anti-Doping  Authority 
(WADA) is one of strict liability, an application of the legal 
proposition  that  ignorance  is  no  excuse  and  the  ultimate 
responsibility  is  on  the  athlete  to  ensure  at  all  times 
whatever is swallowed, injected or applied to the athlete is 
both  safe  and  legal  for  use.  This  means  that  a  violation 
occurs  whether  or  not  the  athlete  intentionally  or 
unintentionally,  knowingly  or  unknowingly,  used  a 
prohibited substance/method or was negligent or otherwise 
at fault. Athletes are therefore expected to understand not 
only  what  is  prohibited,  but  also  what  might  potentially 
cause  an  inadvertent  doping  violation.    Yet,  as  will  be 
discussed,  athlete  knowledge  on  doping  is  deficient  and 
WADA itself sometimes changes its position on prohibited 
methods or substances.  The situation is further confounded 
by  the  conflicting  stance  of  anti-doping  experts  in  the 
media. These highly publicised disagreements may further 
portray  inconsistencies  in  anti-doping  guidelines  and 
suggest  to  athletes  that  what  is  considered  doping  is 
dependent  on  the  dominant  political  zeitgeist.  Taken 
together,  athletes  may  believe  that  unless  a  specific  and 
explicit  ruling  is  made,  guidelines  are  open  to 
interpretation. Therefore doping risk-taking behaviours may 
occur  because  of  the  potential  financial,  social  and 
performance  gains  and  the  optimistically  biased 
interpretation (that trying alternatives is part of the “spirit 
of sport”) and doping risk-taking behaviours may occur.  
 
This discussion paper seeks to situate the reader in a world 
where elite level sports and CAM intersects. It posits that an 
understanding  of  the  underlying  motivation  for  CAM  use 
and doping is currently lacking and  that anti-doping rules 
need  to  be  repositioned  in  the  context  of  the  emerging 
phenomenon and prevalence of CAM use. 
Key Words 
Doping,  complementary  and  alternative  medicine,  sports 
law, biopsychology 
 
 
Background 
Western  medicine  as  is  practiced  in  many  industrialised 
countries  is  generally  regarded  as  conventional,  or 
orthodox, and its use has a long-established history in these 
societies.
1  Interest  and  use  of  complementary  and 
alternative medicine (CAM) has, however, been growing in 
recent  times  in  Western  countries,  as  reflected  by  the 
increasing  number  of  research  papers  in  medical  and 
scientific  journals  [unpublished  literature  search  by  the 
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authors.  Interested  readers  are  referred  also  to  the 
following for further details:].
2-10 
  
Surveys  in  many  countries  have  suggested  a  high  use  of 
CAM: in the United States, about a third of adults aged 18 
years or older use CAM.9.11 Despite this  growing interest, 
the  definition  of  what  is  complementary  or  alternative 
remains  very  subjective  and  is  certainly  not  universally 
accepted.12 
 
While  individual  organisations  have  their  own  definitions, 
the perceptions of the general population or the end-users 
and even the practitioners of the various forms of medicine 
of what constitutes CAM vary tremendously.12 In addition, 
CAM techniques could become co-opted as they enter the 
mainstream.13 More physicians are also seeking training in 
CAM: there is an estimated 3,000 American physicians who 
integrate acupuncture into their practice14 and an estimated 
one-third  of  homeopaths  who  are  physicians  or 
osteopaths.15 The confusion of what constitute CAM (and 
the increasing penetration of CAM in everyday life) – either 
as  a  distinct  treatment  modality  that  consumers  actively 
choose,  or  through  the  integration  of  CAM  into  Western 
medicine – may have serious implications for athletes. 
 
Athletes are highly motivated and many seek new methods 
to  improve  performance.  The  literature  indicates  that 
athletes may also be the highest users of CAM and may help 
pioneer  population  trends  in  CAM  use.16-18  While  non-
athletes  may  use  CAM  for  prevention,  treatment  or 
rehabilitation  from  illness/injuries,  athletes  may  possibly 
also  use  CAM  for  performance  enhancement.  If  links 
between sport motivation and doping exist, and athletes’ 
sport  motivation  and  CAM  use  are  related,  a  connection 
between athletes’ CAM use and doping may also occur. This 
paper  seeks  to  situate  the  reader  in  a  world  where  elite 
level sports and CAM intersects and posits that anti-doping 
rules need to be repositioned in the context of an emerging 
phenomena  and  ubiquitous  prevalence  of  CAM  use.  This 
paper discusses the concept of doping, the issue of using 
natural substances as a doping violation, how acupuncture 
as a type of CAM works, and how the use of CAM may be 
related to doping in the formal context of the spirit of sport.  
 
It is important to note that most international sports are 
governed by rules of Western nations and Western culture 
and  philosophies.  For  example,  the  rules  for  competitive 
swimming and all aquatic sports are governed by Fédération 
Internationale de Natation (FINA), while anti-doping rules in 
all sports are governed by the World Anti-Doping Agency 
(WADA).  The  official  languages  (and  the  inherent  culture 
and worldview) of FINA and the WADA rules are English and 
French  and  where  the  interpretations  of  the  rules  are  in 
doubt, the English language shall prevail. 19-21  
 
With  an  increase  in  the  participation  of  non-Westernised 
countries  in  international  sports,  these  rules  (especially 
those regarding anti-doping) and their interpretation need 
to be sensitive to a multi-cultural environment. This paper 
will  also  explore  how  biopsychological  evidence  in  the 
contexts  of  CAM  use  and  WADA  rules  need  to  be  more 
consistent and better explained to the sporting community. 
 
What is doping? 
It  was  mentioned  earlier  how  the  WADA  is  the  current 
international  governing  body  that  oversees  the  issue  of 
doping in all sports. The WADA has defined doping in their 
World Anti-Doping Code (the "Code", 22). Under the Code, 
a  violation  of  one  or  more  of  the  following  rules  is 
considered  doping  and  may  result  in  sanction:  (i)  the 
presence  of  a  prohibited  substance  or  its  metabolites  or 
markers  in  an  athlete’s  bodily  specimen,  (ii)  the  use  or 
attempted  use  of  a  prohibited  substance  or  a  prohibited 
method,  (iii)  possession  of  prohibited  substances  and 
methods, (iv) administration or attempted administration of 
a prohibited substance or prohibited method to any athlete, 
or (v) assisting, encouraging, aiding, abetting, covering up or 
any other type of complicity involving an anti-doping rule 
violation or any attempted rule violation. 
 
A substance or method is considered for inclusion on the 
WADA’s  prohibited  list  if  the  WADA  determines  that  the 
substance or method meets any two of the following three 
criteria (italics emphasis by this author):
22 
 
1.  Medical  or  other  scientific  evidence, 
pharmacological  effect,  or  experience  that  the 
substance or method has the potential to enhance 
or enhances sport performance.  
2.  Medical  or  other  scientific  evidence, 
pharmacological effect, or experience that the use 
of the substance or method represents an actual or 
potential health risk to the athlete. 
3.  Determination by the WADA that the use of the 
substance or method violates the spirit of sport as 
described in the ‘Introduction to the Code’ (further 
explored below).
22   
 
The  current  emphasis  of  prohibition  also  appears  to  be 
based on four factors: 
 
1.  Substances within the athlete’s body. 
2.  Methods  that  enhance  oxygen  transfer  through 
blood doping or artificial measures.  Australasian Medical Journal [AMJ 2012, 5, 1, 18-25] 
 
 
20 
             
3.  Altering collected body fluid samples. 
4.  Genetic manipulation. 
 
This paper discusses the first two factors. Controversy exists 
as  to  what  are  acceptable  levels  of  naturally  occurring 
endogenous compounds and also what is a method that is 
not considered doping.  
 
The interpretation of the Code is a legal one and  largely 
untested. The broad interpretation of the principles behind 
the  Code  would  seem  to  be  related  to  any  substance  or 
method  that  (potentially  or  actually)  enhances  sport 
performance, becomes a health threat to the athlete, or is 
against the spirit of the sport. If the motivation, and indeed, 
the imperative, of an athlete is to constantly seek creative 
ways to improve the sporting performance, what then is the 
spirit  of  sport,  and  what  actions  are  deemed  to  have 
violated  that  spirit?  Using  a  biopsychological  perspective, 
issues of what are acceptable levels of naturally occurring 
endogenous  compounds,  what  is  a  method  that  is  not 
considered  doping,  and  what  is  the  spirit  of  sport  are 
explored below. 
 
What is unnatural about natural substances? 
Calf-derived  deproteinised  haemodialysate,  Actovegin 
(Nycomed  Austria),  is  a  component  in  calves’  blood  that 
gained attention when its use by the Australian rugby teams 
was  reported23  to  improve  endurance  and  recovery  from 
injuries.  Although  the  medical  research  suggests  some 
evidence (i.e. ‘potential’) of efficacy in the treatment of soft 
tissue  injuries,
24,25  the  Australian  Sports  Anti-Doping 
Authority  (ASADA,  as  a  national  representative  of  the 
international  parent,  WADA)  said  that  Actovegin  was  not 
then on the WADA’s list of prohibited substances.
26 Thus its 
use  as  a  substance  when  restricted  to  intra-muscular 
injections is therefore not prohibited. However, it is illegal 
as a method when injected into a vein.
27,28 
 
Actovegin  was  initially  listed  on  the  banned  list  by  the 
International  Olympic  Committee  (IOC)  (the  leading 
authority  in  anti-doping  prior  to  the  formation  of  the 
WADA) in December 2000 because of the concerns about its 
abuse in cycling. It was, however, removed from the IOC 
banned  list  in  February  2001  pending  further  research.
28 
Actovegin  is  not  a  prohibited  substance  in  WADA’s  most 
current lists,
20,21 although these lists do have an inclusion 
statement not present in previous versions: the prohibition 
of any growth factor(s) affecting muscle, tendon or ligament 
protein  synthesis/degradation,  vascularisation,  energy 
utilisation, regenerative capacity or fibre type switching (p. 
4).  This  inclusion  statement  has,  however,  created  more 
uncertainty  over  other  therapeutic  substances,  besides 
Actovegin, used  in sports medicine  settings  [e.g.  platelet-
rich  plasma:  discussed  in  more  detail  by  Engebretsen  et 
al].
29 So far, the lawful challenge of using Actovegin as  a 
tendon healing substance has not been made, although this 
legal issue is evolving at the time of writing.
30 
 
According  to  the  latest  2012  WADA  prohibited  list,
21 
Actovegin  is  not  prohibited  in  any  sports.  However,  to 
complicate matters, WADA has issued specific guidance on 
Actovegin on its website that, according to section M2 of 
the WADA code, the volume of intravenous injection of any 
non-prohibited  substance  must  not  exceed  50  ml  with  a 
simple syringe, and further serial injections must be at least 
six hours apart.
31 This means that under the latest (2012) 
interpretation  of  the  Code,  Actovegin  cannot  be 
administered by intravenous infusion or single intravenous 
injection with a volume exceeding 50 ml. 
 
Erythropoietin  (EPO)  is  a  peptide  hormone  and  another 
compound that is found in the blood. EPO occurs naturally 
in  the  human  body.  To  boost  the  amount  of  EPO  in  the 
human  body  with  the  aim  of  improving  endurance 
performance  or  to  improve  recovery  from  anaerobic 
exercise, some athletes (e.g. cyclists) may use recombinant 
EPO.  Recombinant  EPO  is  prohibited  both  in  and  out  of 
competition under the World Anti-Doping Code Prohibited 
List,
 20 although raising endogenous EPO in an athlete’s body 
through  the  method  of  high  altitude  training  is  not 
prohibited. 
 
Recombinant EPO use, traditionally difficult to detect in the 
athlete, has recently been successfully tested in athletes as 
a result of collaboration of WADA and the pharmaceutical 
companies in uncovering a molecular marker of the drug.
32 
This  uncovering  process  helps  differentiate  naturally 
occurring  EPO  and  those  artificially  introduced.  A  similar 
technique to detect Actovegin would not be useful if the 
artificial introduction into the human body intramuscularly 
or  using  less  than  50ml  volume  (no  specification  of 
concentration by WADA) intravenously were not prohibited. 
This means that the detection of doping of Actovegin would 
depend on catching athletes in the act of performing the 
banned method (not adhering to the rule of an intravenous 
injection of less than 50ml or an intramuscular injection of 
Actovegin)  and  not  simply  detecting  Actovegin  in  the 
athlete’s body. 
 
The inclusion and subsequent exclusion from the prohibited 
list,  coupled  with  confusing  biological  evidence  and 
scientific perspective is not unique to Actovegin: caffeine, 
considered  a  performance  enhancing  substance,  was  also 
previously classified as a banned substance by WADA if it  Australasian Medical Journal [AMJ 2012, 5, 1, 18-25] 
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was  detected  in  urine  above  a  concentration  of  12 
micrograms  per  millilitre.  Subsequent  scientific  evidence 
suggests  that  caffeine  actually  decreases  performance 
above that 12 micrograms per millilitre threshold,
33 and is 
known  to  be  metabolised  at  very  different  rates  in 
individuals. Thus the risks of sanctioning athletes for simply 
consuming social amounts of caffeine common in drinks and 
food
33 led to the removal of caffeine from WADA’s list of 
banned substance in 2004.
 33  
 
The  inconsistent  stances  on  substances  and  methods 
illustrated  above  may  confuse  athletes,  particularly  when 
interpreted in the context of the spirit of sport (discussed 
later).  This  confusion  may  be  exacerbated  by  consistent 
media  portrayal  of  differences  on  the  legalities  of  using 
Actovegin and caffeine in sports by anti-doping experts.
33.,34 
 
The  next  section  will  discuss  various  possible  ways  that 
acupuncture (as a form of CAM) works physiologically. In 
the  setting  of  expert  debate  on  acceptable  levels  of 
naturally occurring endogenous compounds and what is a 
method  that  is  not  considered  doping,  it  provides  a 
biopsychological basis in the context of doping and spirit of 
sport. 
 
CAM physiology and methods 
Acupuncture [and the field of traditional Chinese medicine 
(TCM)] is arguably an archetype of what is considered CAM 
in Westernised societies.
35 Acupuncture is also increasingly 
being  integrated  into  conventional  medicine  in  these 
communities and is one of the most extensively scientifically 
studied forms of CAM.
12 
 
While  there  is  still  debate  on  the  actual  physiological 
mechanism  of  how  acupuncture  works,  many  scientists 
believe  that  several  mechanisms  are  possible.  Because 
these  proposed  mechanisms  are  different  from  the 
underlying ethos and philosophy that govern acupuncture 
and TCM – the presence of the life energy (or “Qi”) flowing 
through channels (or “meridians”) in the human body
36 – 
and  how  disease  occur,  direct  comparisons  with  the 
scientific  paradigms  of  biomedicine  are  not  always 
possible.
37 Also, individuals may use CAM and TCM due to 
their beliefs in the underlying traditional philosophies rather 
than any scientific motivation.
 38 
 
There  are  several  ways  in  which  acupuncture  may  work. 
Local anaesthesia at needle  insertion  sites may block the 
analgesic  effects  of  acupuncture  which  suggests  that 
acupuncture  is  dependent  upon  neural  innervation.
39 
Acupuncture  may  also  cause  the  release  of  endogenous 
opioids in brain-stem, subcortical, and limbic structures
40,41 
or induce the secretion of adrenocorticotropic hormone and 
cortisol from the pituitary gland thereby creating a systemic 
anti-inflammatory  response.
42  Indeed,  functional  MRI 
studies in humans show that acupuncture modulates limbic 
and  basal  forebrain  areas  involved  in  pain  processing,
43 
while  PET  (positron-emission  tomography)  scans  have 
shown  that  acupuncture  is  able  to  increase  the  opioid 
binding potential in the brain for several days.
44 
 
Other proposed mechanisms of how acupuncture works are 
through  its  ability  to  mechanically  stimulate  connective 
tissues,
45  release  adenosine  at  the  site  of  needle 
stimulation,
46  or  increase  local  blood  flow.
47  Ahmedov
48  
provides  a  more  detailed  discussion  of  the  potential 
ergogenic effects of acupuncture in sport and exercise. As 
an example, an athlete sustained a ruptured muscle fibre 
(traditionally  requiring  prolonged  treatment  periods)  less 
than three weeks before the 1998 European track and field 
championship. Treated with acupuncture, the athlete went 
on to win a silver medal and maintained a high performance 
level without pain.
49 
 
Evidence-based  medicine  requires  large  sample  sizes  and 
preferably randomised-controlled trials to provide statistical 
evidence  of  significant  effects.  The  issue  of  doping, 
however, is as much an interpretation of the law, as it is 
about the scientific and statistical evidence. The Code states 
that  “…regardless  of  whether  the  expectation  of 
performance enhancement is realistic..”.
22 This is discussed 
in the next section. 
 
Regardless of how acupuncture works, if a CAM modality 
such  as  acupuncture  that  does  not  involve  ingestion  of 
(potentially  prohibited)  substances  but  operates  via  a 
physical  method,  is  capable  of  (potentially)  increasing  an 
athlete’s endorphin levels or increasing the athlete’s tissue 
regenerative capacity [and in so doing potentially improves 
athlete performance],
50 is it acceptable under WADA rules? 
Or is it against WADA’s spirit of sport? 
 
Spirit of sport: The ephemeral elephant in the room 
The  WADA  characterises  spirit  of  sport  under  the  Code
22 
(p.14) as: 
 
1.  ethics, fair play and honesty;  
2.  health;  
3.  excellence in performance;  
4.  character and education;  
5.  fun and joy;  
6.  teamwork; dedication and commitment;  
7.  respect for rules and laws;  
8.  respect for self and other participants;   Australasian Medical Journal [AMJ 2012, 5, 1, 18-25] 
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9.  courage;  
10.  community and solidarity.  
 
While these objectives are noble and worthy principles for 
sport,  their  abstract  nature  sometimes  creates  confusion 
when applied to the day-to-day realities that athletes face. 
The Code cites specific issues in the context of the spirit of 
sport, but these add to the confusion. 
 
The WADA states in the Code (9) that the:  
“…  use  of  genetic  transfer  technology  to 
dramatically enhance sport performance should be 
prohibited as contrary to the spirit of sport even if 
it is not harmful...” 
 
and that  
“…  the  potentially  unhealthy  abuse  of  certain 
substances without therapeutic justification based 
on the mistaken belief they enhance performance 
is certainly contrary to the spirit of sport regardless 
of  whether  the  expectation  of  performance 
enhancement  is  realistic…”  (p.33,  italics  by  this 
author for emphasis). 
 
These  seem  at  prima  facie  to  contradict  the  guiding 
principle  of  ‘excellence  in  performance’  set  out  in  the 
characterisation of spirit of sport in the introduction to the 
Code (p. 14). 
 
Athletes  dedicate  their  lives  to  improving  their  sporting 
skills and fitness to be better in their sport. It is acceptable 
(and logical) to enhance performance by physical training 
without adding substances to the athlete’s body. The use of 
varied training programs and orthotic devices by athletes 
(e.g. fins for swimming training) during out-of-competition 
training is standard practice for most sports and one of the 
fundamentals  of  training  paradigms.  Most  such 
performance-enhancing  devices  are,  however,  banned 
during competition.  
 
If  performance  enhancing  devices  are  prohibited  during 
competition,  how  is  the  previous  acceptance  of 
performance  enhancing  polyurethane  swim  suits  by  the 
international  swimming  governing  body,  FINA,
51,52  or  the 
recent acceptance of a performance enhancing “swimwear 
system”  for  the  2012  Olympics
53  reconciled  with  WADA’s 
spirit of sport and FINA’s own rule of ‘No swimmer shall be 
permitted to use or wear any device that may aid his speed, 
buoyancy or endurance during a competition' (FINA, 54, SW 
10.8)? Extending that argument a little further, and in the 
context of CAM, if a CAM that uses a physical modality is 
able  to  enhance  performance,  regardless  of  whether  the 
expectation  of  performance  enhancement  is  realistic,
22  is 
that deemed acceptable and in the spirit of sport, or does it 
violate  WADA’s  doping  regulations?  Should  the  use  of 
acupuncture, for example, to speed up recovery, improve 
flexibility and improve performance during a competition be 
labelled as a prohibited method and/or against the spirit of 
sport? 
 
The finishing line 
If the psychological motivation of athletes is to excel in their 
sport, and there may be a biopsychological basis for using 
CAM to improve their performance, the implications of CAM 
use in the context of elite sport must be recognised.  
 
Whether  using  conventional  medicine  or  CAM,  athletes 
utilise any means to maximise their physical potential. So 
when  does  a  method  that  increases  the  athletes’ 
endogenous  substance  to  improve  sporting  performance 
become  illegal  or  against  the  spirit  of  sport?  There  is  at 
present  an  inconsistent  application  of  what  are  methods 
that are considered illegal or doping and what the spirit of 
sport really is. 
 
Present  day  elite  sport  culture  is  now  less  about  health, 
courage, community and solidarity, or even character and 
education, fun or joy. The majority of athletes presumably 
believe and strive for ethics, fair play, honesty, and most are 
mindful  of  respecting  themselves,  the  other  participants, 
and showing teamwork, and will not knowingly break the 
rules  and  the  law.  While  few  would  disagree  that  elite 
athletes  epitomise  the  virtues  of  dedication  and 
commitment, their ultimate and fundamental motivation is 
ultimately excellence in sporting performance.  
 
Data from non-athlete patients suggests that ingested CAM 
substances are not viewed as medications because they are 
perceived as “natural”.
55-58 Thus athletes may use CAM in 
the  belief  that  it  is  more  natural  and,  erroneously,  not 
potentially  doping  (either  as  a  “method”  or  “substance” 
under the anti-doping Code). The lack of understanding of 
various  forms  of  medicine  by  patients  and  athletes  may 
result in their not informing doctors (or coaches) about non-
conventional  treatment  use  because  it  is  not  viewed  as 
important  or  relevant  to  their  medical  management.
59 
Patients thus risk complications from CAM drugs and their 
interaction with prescribed medications.
60-64 The additional 
consequence  from  failure  to  recognise  CAMs  as 
pharmacological agents puts athletes at risk of inadvertent 
doping.  
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